全文获取类型
收费全文 | 10201篇 |
免费 | 779篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 423篇 |
妇产科学 | 244篇 |
基础医学 | 1378篇 |
口腔科学 | 70篇 |
临床医学 | 1749篇 |
内科学 | 1886篇 |
皮肤病学 | 66篇 |
神经病学 | 876篇 |
特种医学 | 153篇 |
外科学 | 832篇 |
综合类 | 117篇 |
一般理论 | 29篇 |
预防医学 | 1304篇 |
眼科学 | 207篇 |
药学 | 684篇 |
中国医学 | 21篇 |
肿瘤学 | 916篇 |
出版年
2024年 | 12篇 |
2023年 | 105篇 |
2022年 | 132篇 |
2021年 | 231篇 |
2020年 | 204篇 |
2019年 | 275篇 |
2018年 | 279篇 |
2017年 | 224篇 |
2016年 | 257篇 |
2015年 | 249篇 |
2014年 | 339篇 |
2013年 | 529篇 |
2012年 | 811篇 |
2011年 | 833篇 |
2010年 | 444篇 |
2009年 | 401篇 |
2008年 | 719篇 |
2007年 | 748篇 |
2006年 | 727篇 |
2005年 | 675篇 |
2004年 | 614篇 |
2003年 | 542篇 |
2002年 | 544篇 |
2001年 | 69篇 |
2000年 | 43篇 |
1999年 | 89篇 |
1998年 | 115篇 |
1997年 | 85篇 |
1996年 | 93篇 |
1995年 | 85篇 |
1994年 | 57篇 |
1993年 | 58篇 |
1992年 | 33篇 |
1991年 | 37篇 |
1990年 | 31篇 |
1989年 | 22篇 |
1988年 | 32篇 |
1987年 | 23篇 |
1986年 | 18篇 |
1985年 | 23篇 |
1984年 | 22篇 |
1983年 | 22篇 |
1982年 | 19篇 |
1981年 | 26篇 |
1980年 | 26篇 |
1979年 | 11篇 |
1978年 | 12篇 |
1977年 | 7篇 |
1975年 | 9篇 |
1974年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
62.
Heffelfinger SC Yan M Gear RB Schneider J LaDow K Warshawsky D 《Laboratory investigation; a journal of technical methods and pathology》2004,84(8):989-998
Preinvasive mammary pathologies in humans and rat chemical carcinogenesis model systems have an increased microvascular density relative to normal tissue. This suggests the possibility of preventing invasive breast cancer by inhibiting angiogenesis. Vascular endothelial cell growth factor (VEGF) is a potent angiogenic growth factor, commonly involved in tumor-induced angiogenesis. Here, we show that both VEGF and VEGFR2 expression increase with histological progression to invasive disease in the rat 7,12-dimethylbenz[a]anthracene (DMBA) model. Other VEGF receptors, VEGFR1, neuropilin 1 and neuropilin 2, are constitutively expressed throughout progression. To examine whether VEGF signaling is functionally relevant to tumor-induced endothelial tubule formation in vitro and for tumor formation in vivo, we utilized the VEGFR2 inhibitor, ZD6474. In vitro endothelial cell tubulogenesis induced by isolated mammary organoids or carcinoma in situ from DMBA-treated rats is inhibited by ZD6474, in a dose-dependent fashion. The administration of ZD6474 to DMBA-treated rats inhibits the formation of atypical ductal hyperplasia and carcinoma in situ by greater than 95% (P < 0.05), when administered 1 week or 6 weeks post-DMBA initiation. Invasive disease was absent in all ZD6474 cohorts. These data support the hypothesis that progression of DMBA-induced preinvasive mammary pathologies to palpable disease requires angiogenesis via a VEGF-dependent mechanism. 相似文献
63.
Carlo M. Crocem Monica Shander Joanne Martinis Lucienne Cicurel Gian G. D'ancona Hilary Koprowski 《European journal of immunology》1980,10(6):486-488
Loss of human chromosomes from mouse × human hybridomas is not random. Human chromosomes 14, 5 and 22 are preferentially retained, while chromosomes 2 and 1 are preferentially lost. Interestingly, human chromosome 14, which carries the genes for human immunoglobulin heavy chains, appears to be retained by almost all the hybrid clones and subclones. 相似文献
64.
Vivek Kapur Joanne T. Maffei Rebecca S. Greer Ling-Ling Li Gerald J. Adams James M. Musser 《Microbial pathogenesis》1994,16(6)
Virtually all clinical isolates of group A streptococci secrete a highly conserved extracellular cysteine protease that cleaves human fibronectin and vitronectin, and converts IL-1β precursor to biologically active IL-1β. Based on the high degree of gene conservation within the species and its role in host pathogenicity, it was postulated that antibodies to the cysteine protease would confer protective immunity against S. pyogenes infection. To test this hypothesis, Swiss CD1 mice were intraperitoneally administered either saline, rabbit IgG, or IgG from rabbits immunized with the protease, and challenged with a highly virulent (minimum lethal dose 10 cfu) clinical isolate of S. pyogenes expressing a heterologous cysteine protease. The results indicate that mice administered IgG from rabbits immunized with purified cysteine protease had significantly enhanced survival when compared with mice given either non-specific rabbit IgG (log rank test; χ2; p = 0.0195) or saline (log rank test; χ2; p = 0.0002). Moreover, mice actively immunized with the cysteine protease had a significantly longer time to death than the control group (log rank test; χ2; p = 0.0418). The results show that the cysteine protease elicits non-type-specific immunity to challenge with heterologous S. pyogenes. 相似文献
65.
Joanne Hopmeyer Erika Whitney Dana A. Papp Manisha S. Navathe Robert A. Levine Young H. Kim Ajit P. Yoganathan 《Annals of biomedical engineering》1996,24(5):561-572
Mitral regurgitation results from the incomplete closure of the mitral valve, and the noninvasive diagnosis of this disease
remains an important clinical goal. In this study, steady flow computer simulations were used to evaluate flow convergence
method for flow rate estimation. The hemispheric and hemielliptic formulae were compared for accuracy in the presence of complicating
factors such, as ventricular confinement, orifice shape, and aortic outflow. Results showed that in the absence of aortic
outflow and ventricular confinement, there was a plateau zone where the hemispheric formula approximated the true flow rate,
independent of orifice shape. However, in the presence of complicating factors such as aortic outflow and ventricular confinement,
there was no clear zone where the hemispheric formula could be applied. The hemielliptic formula, however, worked in, all
cases, regardless of chamber size or magnitude of aortic outflow. Therefore, application of the hemielliptic formula shold
be considered in future clinical studies. 相似文献
66.
Nucleotide sequence of the coat protein gene of a necrotic strain of potato virus Y from New Zealand 总被引:2,自引:0,他引:2
Summary The sequence of the 3-terminal 1,134 nucleotides of the genome of a New Zealand isolate of a necrotic strain of potato virus Y (PVYN) has been determined. This sequence contains one large open reading frame of 796 nucleotides, the start of which was not identified, which is capable of encoding a protein of 264 amino acid residues with a molecular weight of 29,631. Comparison of the amino acid sequence with a published coat protein sequence of another strain, PVY-D, and with the amino acid sequence deduced from PeMV cDNA sequence data, confirms that the 3 cistron encodes the viral coat protein in PVYN. Adjacent to the 3 end of the coding region there is an untranslatable sequence of 326 nucleotides terminating in a polyadenylate tract. An alignment of the PVYN amino acid sequence with the coat protein sequences of six other potyviruses revealed significant sequence similarities in the internal and carboxy terminal regions. Much amino acid sequence similarity was found between PVYN, PVY-D, and PeMV (91–93%), suggesting that PeMV should be regarded as a PVY strain. An analysis of the 3-untranslated region of the six potyviruses revealed PVYN and PeMV as the only viruses displaying sequence similarity in this region. The 3-untranslated sequences of PVYN and PeMV were further examined for secondary structure. 相似文献
67.
Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. 总被引:1,自引:0,他引:1
Donald Beam Michele D Poe James M Provenzale Paul Szabolcs Paul L Martin Vinod Prasad Suhag Parikh Tim Driscoll Srini Mukundan Joanne Kurtzberg Maria L Escolar 《Biology of blood and marrow transplantation》2007,13(6):665-674
Adrenoleukodystrophy (ALD) is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. The disease typically presents in young boys and adolescent boys. Allogeneic bone marrow transplantation has been used to halt progression of the disease. However, many patients lack suitable HLA- matched related donors and must rely on unmatched donors for a source of stem cells. The purpose of this study was to evaluate outcomes of unrelated donor umbilical cord blood transplantation after chemotherapy-based myeloablative conditioning and retrospectively determine if baseline studies correlate and help predict outcome. Between November 22, 1996, and November 3, 2005, 12 boys with X-linked ALD who lacked HL- matched related donors were referred to Duke University Medical Center for transplantation. These children were conditioned with myeloablative therapy including busulfan, cyclophosphamide, and antithymocyte globulin before receiving umbilical cord-blood transplants from unrelated donors. Baseline studies of neurophysiologic, neuroimaging, and neurodevelopmental status were performed and patients were subsequently evaluated for survival, engraftment, graft-versus-host disease, and neurodevelopmental outcomes. A substudy evaluated whether baseline neuroimaging and neurophysiologic studies correlated with cognitive and motor function and if these studies were predictive of posttransplantation outcomes. The umbilical cord blood grafts had normal levels of very long chain fatty acids. They delivered a median of 6.98 x 10(7) nucleated cells per kilogram of recipient body weight and were discordant for up to 4 of 6 HLA markers. Neutrophil engraftment occurred at a median of 22.9 days after transplantation. Three patients had grade II-IV acute graft-versus-host disease; 2 had extensive chronic graft-versus-host disease. Cumulative incidence of overall survival of the group at 6 months is 66.7% (95% confidence interval 39.9-93.3%). Median follow-up was 3.3 years (range 12 days to 6.3 years). As previously reported with bone marrow transplantation, symptomatic patients faired poorly with lower survival and rapid deterioration of neurologic function. This study included 3 patients transplanted at a very young age (2.6-3.5 years) before the onset of clinical symptoms who continue to develop at a normal rate for 3-5 years posttransplant. Although baseline Loes scores correlated with cognitive and motor outcome, neurophysiologic studies failed to show statistically significant differences. Transplantation of boys with X-linked ALD using partial HLA-matched umbilical cord blood yields similar results to those previously reported after bone marrow transplantation. Superior outcomes were seen in neurologically asymptomatic boys less than 3.5 years of age at the time of transplantation. Baseline Loes scores were a strong predictor of cognitive and motor outcome. 相似文献
68.
Jennifer E. Reynolds Joanne M. Meyer Barbara Landa Cathy A. Stevens Kathleen S. Arnos Jamie Israel Mary L. Marazita Joann Bodurtha Walter E. Nance Scott R. Diehl 《American journal of medical genetics. Part A》1995,57(4):540-547
Expression of clinical findings of Waardenburg syndrome type 1 (WS1) and type 2 (WS2) is extremely variable. Using our collection of 26 WS1 and 8 WS2 families, we analyzed the occurrence, severity, and symmetry of clinical manifestations associated with WS. We found significant differences between WS1 and WS2 in deafness, and in pigmentary and craniofacial anomalies. Factor analysis was used to identify manifestations which covaried, resulting in 2 orthogonal factors. Since mean factor scores were found to differ when compared between WS1 and WS2, we suggest that these factors could be useful in distinguishing WS types. We found that the WS gene was transmitted from mothers more often than from fathers. We also extensively examined the W-Index, a continuous measure of dystopia canthorum. Our data suggest that use of the W-Index to discriminate between affected WS1 and WS2 individuals may be problematic since 1) ranges of W-Index scores of affected and unaffected individuals over-lapped considerably within both WS1 and WS2, and 2) a considerable number of both affected and unaffected WS2 individuals exhibited W-index scores consistent with dystopia canthorum. Misclassification of families may have implications for risk assessment of deafness, since WS2 families have been reported to have greater incidence of deafness, as confirmed in our study. © 1995 Wiley-Liss, Inc. 相似文献
69.
70.
Observations that cells of the immune system are able to kill tumor cells both in vitro and in animal models have provided a compelling rationale for pursuit of a strategy whereby immune cells are administered as a therapeutic vaccine to patients with cancer. The successful outcome of this approach depends upon the ability to deliver this therapy in a manner in which a potent immune response is elicited. By harnessing the capacity of dendritic cells that are pivotal in priming the immune response and using gene therapy approaches to optimise the immune response, this may ultimately prove efficacious in the management of human cancer. Promising reports from recent clinical trials suggest that this may well be a realistic goal. 相似文献